These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 7779120

  • 1. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.
    Hassfeld W, Steiner G, Studnicka-Benke A, Skriner K, Graninger W, Fischer I, Smolen JS.
    Arthritis Rheum; 1995 Jun; 38(6):777-85. PubMed ID: 7779120
    [Abstract] [Full Text] [Related]

  • 2. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins--a link between RA, SLE and MCTD.
    Steiner G, Skriner K, Hassfeld W, Smolen JS.
    Mol Biol Rep; 1996 Jun; 23(3-4):167-71. PubMed ID: 9112225
    [Abstract] [Full Text] [Related]

  • 3. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice.
    Steiner G, Shovman O, Skriner K, Gilburd B, Langevitz P, Miholits M, Hoet R, Levy Y, Zandman-Goddard G, Hoefler E, Smolen JS, Shoenfeld Y.
    Clin Exp Rheumatol; 2002 Jun; 20(4):517-24. PubMed ID: 12180437
    [Abstract] [Full Text] [Related]

  • 4. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, Steiner G.
    J Clin Invest; 1997 Jul 01; 100(1):127-35. PubMed ID: 9202064
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases.
    Steiner G, Skriner K, Smolen JS.
    Int Arch Allergy Immunol; 1996 Dec 01; 111(4):314-9. PubMed ID: 8957102
    [Abstract] [Full Text] [Related]

  • 6. [Autoantibodies to the heterogeneous nuclear ribonucleoproteins and the autoimmune diseases].
    Yang L, Yu M, Yang C.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug 01; 21(4):311-4. PubMed ID: 12567457
    [Abstract] [Full Text] [Related]

  • 7. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis.
    Montecucco C, Caporali R, Cobianchi F, Biamonti G.
    Arthritis Rheum; 1996 Oct 01; 39(10):1669-76. PubMed ID: 8843857
    [Abstract] [Full Text] [Related]

  • 8. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS.
    Arthritis Rheum; 1998 Nov 01; 41(11):1938-45. PubMed ID: 9811047
    [Abstract] [Full Text] [Related]

  • 9. Anti-RA33 autoantibodies may recognize epitopes in the N-terminal region of hnRNP-A2 (RA33).
    Skriner K, Steiner G, Sommergruber WH, Sinski A, Smolen JS.
    Clin Exp Rheumatol; 1994 Nov 01; 12 Suppl 11():S79-82. PubMed ID: 7539351
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
    Combe B, Rucheton M, Graafland H, Lussiez V, Brunel C, Sany J.
    Clin Exp Immunol; 1989 Jan 01; 75(1):18-24. PubMed ID: 2702772
    [Abstract] [Full Text] [Related]

  • 13. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
    Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A.
    Autoimmunity; 2007 May 01; 40(3):223-33. PubMed ID: 17453722
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to hnRNP core protein A1 in connective tissue diseases.
    Astaldi Ricotti GC, Bestagno M, Cerino A, Negri C, Caporali R, Cobianchi F, Longhi M, Maurizio Montecucco C.
    J Cell Biochem; 1989 May 01; 40(1):43-7. PubMed ID: 2745573
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
    Konig MF, Giles JT, Nigrovic PA, Andrade F.
    Ann Rheum Dis; 2016 Nov 01; 75(11):2022-2028. PubMed ID: 26865600
    [Abstract] [Full Text] [Related]

  • 16. Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera.
    Barakat S, Briand JP, Abuaf N, van Regenmortel MH, Muller S.
    Clin Exp Immunol; 1991 Oct 01; 86(1):71-8. PubMed ID: 1717192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice.
    Hayer S, Tohidast-Akrad M, Haralambous S, Jahn-Schmid B, Skriner K, Trembleau S, Dumortier H, Pinol-Roma S, Redlich K, Schett G, Muller S, Kollias G, Smolen J, Steiner G.
    J Immunol; 2005 Dec 15; 175(12):8327-36. PubMed ID: 16339574
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.